Prothena Corp Public (PRTA) Tax Provisions (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly Tax Provisions came in at $1000.0 in Q1 2026, up 100.08% year-on-year from $499.79 in Q1 2025, and up 102.7% quarter-over-quarter from -$37000.0 in Q4 2025.
Prothena Corp Public (PRTA) Tax Provisions (2012 - 2026) Analysis & Trends
Prothena Corp Public's Tax Provisions history runs 15 years deep, the most recent figure standing at $1000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions rose 100.08% year-over-year to $1000.0 in Q1 2026; TTM through Mar 2026 was $44.4 million, a 906.95% increase from a year earlier, with the FY2025 full-year figure at $43.3 million, up 753.52% from the prior year.
- Tax Provisions climbed to $1000.0 in Q1 2026 per PRTA's latest filing, from -$37000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $44.8 million in Q2 2025 and bottomed at -$4.3 million in Q2 2023.
- The 5-year median for Tax Provisions is -$1.7 million (2022), against an average of $855882.4.
- Across the five-year window, Tax Provisions slumped 6630.43% in 2022 and jumped 2340.1% in 2025, its largest moves.
- Year by year, Tax Provisions stood at -$3.0 million in 2022, then fell by 4.59% to -$3.1 million in 2023, then jumped by 51.62% to -$1.5 million in 2024, then surged by 97.57% to -$37000.0 in 2025, then jumped by 102.7% to $1000.0 in 2026.
- Per Business Quant, the three latest PRTA Tax Provisions figures stand at $1000.0 (Q1 2026), -$37000.0 (Q4 2025), and -$400000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Sep 30, 2025 | -400,000.00 |
| Jun 30, 2025 | 44.80 Mn |
| Mar 31, 2025 | -1.18 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -800,000.00 |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -2.20 Mn |
| Dec 31, 2023 | -3.14 Mn |
| Sep 30, 2023 | -3.10 Mn |
| Jun 30, 2023 | -4.30 Mn |
| Mar 31, 2023 | -2.90 Mn |
| Dec 31, 2022 | -3.00 Mn |
| Sep 30, 2022 | -2.70 Mn |
| Jun 30, 2022 | -1.30 Mn |
| Mar 31, 2022 | -1.67 Mn |
| Dec 31, 2021 | 46,000.00 |
| Sep 30, 2021 | -51,000.00 |
| Jun 30, 2021 | 300,000.00 |